Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Neurology Experts Review Novel Approaches to Understanding Nervous System Diseases and Topics in Clinical Neuroscience

The Annals of the New York Academy of Sciences releases "The Year in Neurology 2."

Published February 03, 2010


Cutting-edge topics in clinical neuroscience and several novel approaches to understanding neurological disease are reviewed in a new volume of the Annals of the New York Academy of Sciences, published by Wiley-Blackwell.

"The Year in Neurology 2," Annals volume 1184, January 2010, includes 14 reviews by leading experts in neurology and neuroscience covering novel approaches to the understanding of neurological diseases through basic science and clinical approaches. The first "Year in Neurology" volume was published in October, 2008.

According to volume editor, Dr. Richard T. Johnson, Professor of Neurology and Neuroscience at The Johns Hopkins University School of Medicine and Professor of Molecular Microbiology and Immunology at The Johns Hopkins University Bloomberg School of Public Health, the reviews are focused on interesting or novel approaches to understanding neurological diseases. "Topics range from an update of vertebrobasilar dolichoesctasia, which intrigued me as a resident 50 years ago, to neurological nanotechnology, a topic of the future," Johnson says.

Among the 14 reviews in the volume are:
• "Sleep disorders in children," by Timothy Hoban, a clinical professor at C.S. Mott Children's Hospital;
• "REM sleep behavior disorder," by Bradley Boeve, Chair of the Behavioral Neurology Departments at the Mayo Clinic;
• "Neurological complications of immune reconstitution in HIV-infected populations," by Tory Johnson, a doctoral candidate, and Avindra Nath, Director, Division of Neuroimmunology and Neurological Infections, at The Johns Hopkins Hospital; and,
• "Advances in treatment of neurodegenerative diseases employing nanotechnology," by Girish Modi, Viness Pillay, and Yahya Choonara, of University of the Witwatersrand, School of Neurosciences, Department of Neurology.

Members of the media may obtain copies of the volume or online access by contacting Douglas Braaten, PhD, Director and Executive Editor, the Annals of the New York Academy of Sciences, at, or (212) 298-8634.

About the Annals of the New York Academy of Sciences
Continuously published since 1823, the Annals of the New York Academy of Sciences is the Academy's premier scholarly publication, offering proceedings of Academy and other scientific conferences, annual reviews in key disciplines, and selected topical collections. Published 32 volumes a year, the Annals provides cross-disciplinary perspectives on research for both the broad scientific community and the society at large. Although primarily focused in biomedicine and biology, the Annals' scope extends to fields such as astronomy, psychology, anthropology, and philosophy. Each volume presents a comprehensive treatment of each field of investigation at a time when emerging developments offer the promise of new insight. These volumes stimulate new ways to think about science by providing a neutral forum for discourse within and across many institutions and fields.

About the New York Academy of Sciences
Founded in 1817, the New York Academy of Sciences (NYAS) is an independent, nonprofit organization committed to advancing science, technology, and society worldwide. With about 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.

About Wiley-Blackwell
Wiley-Blackwell is the international scientific, technical, medical and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes over 1,400 peer-reviewed journals as well as 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit or